【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 13
2 Introduction 14
2.1 Cardiovascular Prosthetic Devices Overview 14
3 Products under Development 15
3.1 Cardiovascular Prosthetic Devices – Pipeline Products by Stage of Development 15
3.2 Cardiovascular Prosthetic Devices – Pipeline Products by Segment 16
3.3 Cardiovascular Prosthetic Devices – Pipeline Products by Territory 17
3.4 Cardiovascular Prosthetic Devices – Pipeline Products by Regulatory Path 18
3.5 Cardiovascular Prosthetic Devices – Pipeline Products by Estimated Approval Date 19
3.6 Cardiovascular Prosthetic Devices – Ongoing Clinical Trials 20
4 Cardiovascular Prosthetic Devices – Pipeline Products under Development by Companies 21
4.1 Cardiovascular Prosthetic Devices Companies – Pipeline Products by Stage of Development 21
4.2 Cardiovascular Prosthetic Devices – Pipeline Products by Stage of Development 24
5 Cardiovascular Prosthetic Devices Companies and Product Overview 27
5.1 4tech Cardio Ireland Limited Company Overview 27
5.1.1 4tech Cardio Ireland Limited Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Agamit Medical Ltd. Company Overview 29
5.2.1 Agamit Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29
5.3 Ample Medical Inc. Company Overview 30
5.3.1 Ample Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Amsel Medical Corporation Company Overview 31
5.4.1 Amsel Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Aporo Biomedical, Inc. Company Overview 32
5.5.1 Aporo Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.6 Arbor Surgical Technologies, Inc. Company Overview 35
5.6.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.7 BioStable Science & Engineering, Inc. Company Overview 36
5.7.1 BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.8 BioVentrix, Inc. Company Overview 40
5.8.1 BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.9 CARAG AG Company Overview 44
5.9.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 44
5.10 Cardica, Inc. Company Overview 46
5.10.1 Cardica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.11 Cardiosolutions, Inc. Company Overview 49
5.11.1 Cardiosolutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Cardious, Inc. Company Overview 50
5.12.1 Cardious, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Celyad SA Company Overview 51
5.13.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Children’s Hospital Boston Company Overview 53
5.14.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 53
5.15 Cierra, Inc. (Inactive) Company Overview 57
5.15.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 CoAptus Medical Corporation Company Overview 58
5.16.1 CoAptus Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 58
5.17 CollPlant Ltd. Company Overview 60
5.17.1 CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
5.18 coramaze technologies GmbH Company Overview 61
5.18.1 coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 61
5.19 Cordis Corporation Company Overview 62
5.19.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 62
5.20 Coroneo Inc. Company Overview 63
5.20.1 Coroneo Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.21 CUBE SRL Company Overview 64
5.21.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 64
5.22 Edwards Lifesciences Corporation Company Overview 65
5.22.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 65
5.23 Emory University Company Overview 72
5.23.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 72
5.24 Guided Delivery Systems, Inc. Company Overview 75
5.24.1 Guided Delivery Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.25 Instituto de investigacion sanitaria Marques de Valdecilla Company Overview 78
5.25.1 Instituto de investigacion sanitaria Marques de Valdecilla Pipeline Products & Ongoing Clinical Trials Overview 78
5.26 IPI Singapore Company Overview 79
5.26.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 79
5.27 Kardium Inc. Company Overview 80
5.27.1 Kardium Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.28 Lartim Medical Ltd Company Overview 81
5.28.1 Lartim Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.29 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 82
5.29.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 82
5.30 Mardil Medical, Inc. Company Overview 83
5.30.1 Mardil Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.31 Mayo Clinic. Company Overview 84
5.31.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 84
5.32 Medtentia AB Company Overview 85
5.32.1 Medtentia AB Pipeline Products & Ongoing Clinical Trials Overview 85
5.33 MiCardia Corporation Company Overview 89
5.33.1 MiCardia Corporation Pipeline Products & Ongoing Clinical Trials Overview 89
5.34 Michigan Critical Care Consultants, Inc. Company Overview 92
5.34.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 92
5.35 Middle Peak Medical, Inc Company Overview 94
5.35.1 Middle Peak Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 94
5.36 Millipede, LLC Company Overview 95
5.36.1 Millipede, LLC Pipeline Products & Ongoing Clinical Trials Overview 95
5.37 Mitral Heal Company Overview 96
5.37.1 Mitral Heal Pipeline Products & Ongoing Clinical Trials Overview 96
5.38 Mitralign, Inc. Company Overview 97
5.38.1 Mitralign, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.39 Mitralix Ltd. Company Overview 105
5.39.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 105
5.40 Mitre Medical Corp. Company Overview 106
5.40.1 Mitre Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview 106
5.41 MValve Technologies Ltd. Company Overview 108
5.41.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 108
5.42 Neochord, Inc. Company Overview 109
5.42.1 Neochord, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
5.43 Occlutech International AB Company Overview 112
5.43.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 112
5.44 Phoenix Cardiac Devices, Inc. Company Overview 119
5.44.1 Phoenix Cardiac Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 119
5.45 QuantumCor Inc. (Inactive) Company Overview 120
5.45.1 QuantumCor Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 120
5.46 ReCor Medical, Inc. Company Overview 121
5.46.1 ReCor Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
5.47 SCR, Inc. Company Overview 124
5.47.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.48 SeptRx, Inc. Company Overview 125
5.48.1 SeptRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.49 Sorin S.p.A. (Inactive) Company Overview 128
5.49.1 Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128
5.50 St. Jude Medical, Inc. Company Overview 130
5.50.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.51 Sutura, Inc. (Inactive) Company Overview 137
5.51.1 Sutura, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 137
5.52 Swissimplant AG (Inactive) Company Overview 139
5.52.1 Swissimplant AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139
5.53 The Tel Aviv Sourasky Medical Center Company Overview 141
5.53.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 141
5.54 TransCardiac Therapeutics, LLC Company Overview 142
5.54.1 TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 142
5.55 Trinity College Dublin Company Overview 143
5.55.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 143
5.56 University of Minnesota Company Overview 144
5.56.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 144
5.57 Valcare Medical Company Overview 145
5.57.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 145
5.58 Valtech Cardio Ltd. Company Overview 146
5.58.1 Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 146
5.59 Viacor, Inc. Company Overview 153
5.59.1 Viacor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153
5.60 Vir(Sn), Inc. Company Overview 156
5.60.1 Vir(Sn), Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.61 W. L. Gore & Associates, Inc. Company Overview 157
5.61.1 W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
6 Cardiovascular Prosthetic Devices- Recent Developments 162
7 Appendix 184
7.1 Methodology 184
7.2 About GlobalData 186
7.3 Contact Us 187
7.4 Disclaimer 187
【レポート販売概要】
■ タイトル：世界の人工心血管置換装置開発動向：医療機器パイプライン分析2015■ 英文：Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0139EPD
■ 調査対象地域：グローバル
- 医薬品有効成分（API）の世界市場2017-2021About Active Pharmaceutical IngredientsA drug is generally composed of APIs and excipients. Active Pharmaceutical Ingredients are chemical compounds or a combination of compounds that are used primarily to have the desired effect on biological systems. Excipients are inactive ingredients in a drug that are used to disperse APIs. APIs may be synthesized either through chemical or biotechnological m …
- IoTマネジードサービスの世界市場予測（～2021年）Growing inclination toward cost-efficient managed services is expected to drive the growth of the IoT managed services marketThe IoT managed services market size is expected to grow from USD 21.85 billion in 2016 to USD 79.60 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 29.5% during the period 2016–2021. The major drivers for the upsurge in demand for the IoT managed services market …
- GPSアンチ・ジャミング（妨害対抗）の世界市場予測（～2022）The global Anti-jamming market for GPS is expected to exhibit a good growth potential till 2022. The overall market is expected to reach USD 4.80 Billion (in terms of value) and 309.2 thousand units (in terms of volume) by 2022, at a CAGR of 7.0% and 10.1%, respectively, between 2016 and 2022. The increasing demand for secured weapons guided systems, increasing vulnerability of GPS signals due to …
- 水リサイクル及び再利用の世界市場2015-2019About Water Recycle and Reuse Water recycling is a process of reusing treated wastewater for useful purposes such as industrial processes, agricultural and landscape irrigation, domestic and commercial usage, and ground water recharge. Wastewater can be tailored to meet the requirements of specific planned application through the process of recycling. The production of recycled water is also refer …
- 世界のスルホサクシネート市場2015The Global Sulfosuccinate Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Sulfosuccinate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Sulfosuccinate market analysis is provided for the international markets including development trends, compe …
- 活性ケイ酸カルシウムの世界市場分析：用途別（絶縁、塗料＆コーティング剤、防火、セメント、セラミックス）、地域別、セグメント予測 2014-2025The global active calcium silicate market is expected to reach USD 203.0 million by 2025, according to a new report by Grand View Research, Inc. Increasing demand from ceramic industry is key growth factor driving active calcium silicate market. In addition, presence of fire safety standards in major economies such as U.S., Germany, China, India, and Brazil are further fueling the demand over the …
- Rytary/IPX066 (パーキンソン病)：医薬品市場予測及び分析（～2022）Rytary/IPX066 (Parkinson’s Disease) - Forecast and Market analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elde …
- ICT投資の優先順位：金融産業部門 – 企業のICT投資計画Why was the report written? In order to provide deeper insights into financial market institutions’ ICT investment priorities and strategic objectives. What is the current market landscape and what is changing? The survey shows that the adoption of cloud computing is relatively low, owing to concerns relating to security and reliability. What are the key drivers behind recent market changes? Finan …
- Compression Therapy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Compression Therapy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Compression Therapy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Compression Therapy market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segme …
- インドの防衛産業におけるFDI（直接投資）機会The Indian Ministry of Defense has been focusing on filling the gaps in the inventory held by Indian armed forces. It has also been focusing on encouraging procurement of defense equipment from indigenous manufacturers. It has initiated the process of signing various contracts with the private sector under the Buy-Make category of the DPP. This is also expected to lead to various partnerships betw …
- 機械制御システムの世界市場予測2022：トータルステーション（TS）、GNSS、レーザースキャナー、航空システム、GIS収集器The machine control system market is expected to be valued at USD 8.16 Billion by 2022, growing at a CAGR of 13.9% between 2016 and 2022. The growth of this market is propelled by the rising demand for precision and the enhanced productivity and optimized operations in the construction, transportation, and agriculture industries. Total stations are expected to hold the largest share of the machine …
- 世界のオレオケミカル脂肪酸市場2015The Global Oleochemical Fatty Acids Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Oleochemical Fatty Acids industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Oleochemical Fatty Acids market analysis is provided for the international markets inclu …
- フッ化水素の世界市場2015Anhydrous Hydrogen Fluoride (CAS 7664-39-3) Market Research Report 2015 aims at providing comprehensive data on Anhydrous Hydrogen Fluoride market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Anhydrous Hydrogen Fluoride description, covers its application areas, manufacturing methods, patterns. It captures Anhydrous Hydrogen Fluoride market trends, …
- ソース及びドレッシングの世界市場About Sauces and Dressings Sauces are usually used as a dip, a glaze, a filling, and an accompaniment with food. The most common types of sauces used by consumers worldwide are tomato sauce (ketchup), soy sauce, mustard sauce, chili sauce, béchamel sauce, and hollandaise sauce. Whereas dressings are used for garnishing and giving taste to food products, especially salads, burgers, sandwiches, and …
- 世界のシリコンフォトニクス市場分析及び予測The silicon Photonics technology is gaining ground as a low cost alternative technology that can address speed and bulk data transfer challenges faced by microelectronics. The silicon Photonics market is in its infancy and is expected to be fully commercialized in all application sectors by 2016. This research study on the Silicon Photonics market focuses on various product segments such as Silico …
